Symbol: |
MRAS
|
Description: |
muscle RAS oncogene homolog [Source:HGNC Symbol;Acc:7227]
|
Location: |
Chr3:138066539-138124375[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:222
Gene |
Compound |
Gen_sig |
Exp_pattern |
MRAS |
6H-Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- |
0.044 |
Down |
MRAS |
Cromolyn sodium |
0.043 |
Down |
MRAS |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.003 |
Up |
MRAS |
Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- |
0.034 |
Down |
MRAS |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.003 |
Up |
MRAS |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.004 |
Up |
MRAS |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.004 |
Up |
MRAS |
NSC 138333 |
0.04 |
Down |
MRAS |
Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- |
0.026 |
Down |
MRAS |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.012 |
Up |
MRAS |
NSC 148201 |
0.007 |
Up |
MRAS |
Pimozide |
0.038 |
Down |
MRAS |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.003 |
Up |
MRAS |
NSC 175296 |
0.009 |
Up |
MRAS |
6-Aminotoyocamycin |
0.041 |
Up |
Expression pattern: Sensitivity / Resistance
Total:15 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:62
Total:5 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
|